Anumana and Pfizer Partner to Enable Early Detection of Underdiagnosed Cardiovascular Disease

Related Articles
Anumana Makes Educated Inferences in Heart Failure
Anumana was founded in 2021 as the culmination of a joint effort between the Mayo Clinic and nference, an early entrant to the field of machine learning for cardiology-focused clinical…February 01, 2026
Anumana expands AI cardiac care platform with support from Boston Scientific
Anumana announced today that it brought its diagnostic ECG-AI technology into perioperative and acute cardiac care with help from Boston Scientific. Read more on massdevice.comApril 24, 2025
Fierce Medtech’s 2022 Fierce 15
Fierce Medtech: Since its humble beginnings back in 2012, the Fierce 15 has made a point of spotlighting the most exciting startups in medtech—those not only challenging the limits of…March 20, 2023
Anumana Appoints Harry S. Palmin as CFO
Anumana Appoints Harry S. Palmin as CFOCAMBRIDGE, Mass. – May 14, 2024 Anumana, a leading AI-driven health technology company and portfolio company of nference, today announced the appointment of Harry…May 14, 2024


